Navigation Links
Lucentis in Medical News

Because of Its Ability to Generate Higher Total Sales in the United States and Europe, Lucentis Will Earn Clinical Gold Standard Status by 2011 for the Treatment of Diabetic Retinopathy

A Drug with Superior Efficacy to Avastin at Improving Visual Acuity When Used with Laser Photocoagulation Would Earn a 20 Percent Patient Share, According to a New Report from Decision Resources WALTHAM, Mass., June 26 /PRNewswire/ -- Decision Resources, one of the world's leading ...

Genentech/Roche's Lucentis and Eli Lilly's Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets

Longer Term Growth of Diabetic Neuropathy Market Will Be Driven by Launches of Disease-Modifying Therapies, According to a New Report from Decision Resources WALTHAM, Mass., Sept. 24 /PRNewswire/ -- Decision Resources, one of the world's leading research and advis...

FDA Approval For Lucentis

The first drug proven to significantly improve the vision of elderly patients was approved by the FDA on Friday//. The drug, Lucentis, is to treat age-related macular degeneration in its wet form, where blood vessels behind the retina leak, worsening vision and often leading to blindness. 90 ...

PDL BioPharma Announces Second Quarter 2009 Financial Results

...0 to $325 million excluding MedImmune royalties. Revenue growth expectations are primarily driven by increases in product sales of Avastin, Herceptin, lucentis and Tysabri. PDL expects its general and administrative expenses for 2009 to range from $20 to $22 million, of which approximately 50 percent...

QLT Announces Second Quarter Results for 2009

...tudy is to evaluate whether Visudyne combined with lucentis is not inferior to lucentis monotherapy with respect to the mean change from b...line compared with a 4.4 letter improvement in the lucentis monotherapy group. In the combination therapy grou...

QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy

...tudy is to evaluate whether Visudyne combined with lucentis is not inferior to lucentis monotherapy with respect to the mean change from b...line compared with a 4.4 letter improvement in the lucentis monotherapy group. In the combination therapy grou...

QLT announces positive results from the evaluation of Visudyne(R) combination therapy

...he study is to determine if Visudyne combined with lucentis reduces retreatment rates compared with lucentis monotherapy, while maintaining similar vision outc...entis combination therapies were evaluated against lucentis monotherapy. The overall results showed that fewer...

Burrill & Company Announces Promotions

...Vygantas - Before joining Burrill in 2006, Garrett was with Genentech's Market Planning Group where he focused on the commercialization and launch of lucentis for the treatment of wet age-related macular degeneration. Dr. Vygantas completed his Transitional Residency at the University of Pennsylvania and h...

QLT announces interim results of radical study evaluating Visudyne combination therapy

...ion therapies (with or without dexamethasone) with lucentis monotherapy in 162 subjects with choroidal neovasc...s were lower in the combination groups than in the lucentis monotherapy group; however, it is too early to dra...the mandatory retreatments at month 1 and 2 in the lucentis monotherapy group. The primary endpoint results at...

FDA Grants NeoVista's Request to Utilize Novel Wet AMD Treatment in Compassionate Case

...y and efficacy of NeoVista's epiretinal brachytherapy delivered concomitantly with the FDA-approved anti-VEGF therapy Lucentis(R) (ranibizumab) versus lucentis alone. About NeoVista, Inc. NeoVista, Inc. is a privately held development-stage medical device company based in Fremont , Calif...
Lucentis in Medical Technology

Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

...ported patients who received Xibrom in addition to lucentis (the Combination Group) required 1.6 +/- 0.69 injections of lucentis during the six-month study period, while patients who received lucentis only received 4.5 +/- 0.41 injections (p=0.0002). ...

FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S.

...ngiogenic therapy Lucentis(R) (ranibizumab) versus lucentis alone. For those enrolled in the trial arm utilizing brachytherapy, lucentis is injected once at the time of the surgery and on...y of epiretinal brachytherapy plus Lucentis versus lucentis alone based on the proportion of subjects losing f...

NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society

... of NeoVista's epiretinal beta radiation therapy delivered concomitantly with the FDA-approved antiangiogenic therapy Lucentis(R) (ranibizumab) versus lucentis alone. About NeoVista, Inc. NeoVista, Inc. is a privately held development-stage medical device company based in Fremont, California. NeoVista's e...

ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)

...eceived Xibrom required 1.6 +/- 0.69 injections of lucentis during the six-month study period, while patients who received only lucentis received 4.5 +/- 0.41 injections. Patients with lucentis alone received significantly more (2.83 times) inj...

Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD

...re-FirstCall/ -- Opko Health Inc. (Amex: OPK ) today announced that the first patient has been dosed in the Phase 3 COBALT (Combining Bevasiranib And lucentis Therapy) clinical trial of bevasiranib for the treatment of wet age-related macular degeneration (wet AMD). The multi- national trial will include mor...
Lucentis in Biological Technology

Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe

However, Off-Label Use of Avastin Will Take Market Share Away from Lucentis from 2012 to 2017, According to a New Report from Decision Resources WALTHAM, Mass., March 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcar...

PDL BioPharma Announces First Quarter 2009 Financial Results

... to ongoing legal activities as discussed above. Revenue growth expectations are primarily driven by increases in product sales of Avastin, Herceptin, lucentis and Tysabri. PDL continues to expect its general and administrative expenses for 2009 to range from $12 million to $15 million, of which approxi...

EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention

...earn videos about eye anatomy, AMD symptoms, dry and wet macular degeneration, diagnostic tests, photodynamic therapy (PDT), intravitreal injection of lucentis and Avastin, vitamin therapy, amsler grid testing, lasers and more. Users also have the ability to browse an FAQ section, which contains expert ...
Other Tags
(Date:8/27/2014)... What’s next for 14 year old Sriram ... National Spelling Bee? Sririam will visit Philadelphia on Friday, ... Wills Eye Hospital.     , The teen from Painted Post, ... day. , Wills Eye Ophthalmologist-in-Chief, Dr. Julia Haller will ... visual diagnostic testing. He will also tour historic ...
(Date:8/27/2014)... The newest Abington Health Center ... 2014. This new 15,000 square foot, $5 million project ... practices and walk-in laboratory services. , “Adding ... for Abington Health as the healthcare landscape changes,” said ... a location in Lower Gwynedd allows us to consolidate ...
(Date:8/27/2014)... -- Overconfident people are better at convincing others that ... are more likely to get promotions and reach high-level ... that these "self-deceived" people are also more likely to ... And finally, people who underestimate themselves are regarded ... British researchers. Their findings were published Aug. 27 in ...
(Date:8/27/2014)... Recent growth in health care spending for commercially insured ... medical services, rather than increased use, according to a ... for Health Policy & Clinical Practice, published in the ... Care . , There is increasing concern that consolidation ... prices faced by payers and, ultimately, consumers," said Carrie ...
(Date:8/27/2014)... August 27, 2014 Driven by the ... is expected to grow steadily during the next few ... reach 1.381 billion meters by end-2017. Tightness is an ... are one of the most-used parts in an automobile. ... stood at 995 million meters, up just under 15% ...
Breaking Medicine News(10 mins):Health News:Scripps National Spelling Bee Co-Champion and Aspiring Ophthalmologist Coming to Wills Eye Hospital in Philadelphia 2Health News:Abington Health Opens New Health Center in Lower Gwynedd 2Health News:Overconfident Folks May Blind Others to Their Real Abilities 2Health News:Tracking spending among the commercially insured 2Health News:Automobile Weatherstrip Sector in China Analysed in New SinoMarketInsight Research Study Published at MarketPublishers.com 2Health News:Automobile Weatherstrip Sector in China Analysed in New SinoMarketInsight Research Study Published at MarketPublishers.com 3
(Date:8/27/2014)... requires nerve cells to rearrange existing patterns of activity ... patterns, a study of monkeys has found. The scientists ... electrical activity of brain cell networks. The study was ... "We looked into the brain and may have seen ... said Aaron Batista, Ph.D., an assistant professor at the ...
(Date:8/27/2014)... By manipulating neural circuits in the brain of ... specific memories. The research, led by Howard Hughes ... Institute of Technology (MIT), reveals that the connections ... contextual information about an experience and the part ... of that experience are malleable. , Altering ...
(Date:8/27/2014)... 27, 2014 University of Utah biologist agan Sekercioglu, ... has won that nation,s highest science prize, which is ... Sekercioglu is among five researchers picked for 2014 the ... Council of Turkey. Three researchers won the Science Award ... Award, which is equivalent to the Science Award but ...
Breaking Biology News(10 mins):Scientists plug into a learning brain 2Scientists plug into a learning brain 3Researchers change the emotional association of memories 2Researchers change the emotional association of memories 3Researchers change the emotional association of memories 4University of Utah biologist wins Turkey's top science prize 2
Other Contents